Enterprise Trust & Investment’s Elevance Health ELV Stock Holding History

Enterprise Trust & Investment’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$10K	Buy	+21	New	+$10.4K	﹤0.01%	217

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Enterprise Trust & Investment's ELV Position: Q2 2022 in Review

Enterprise Trust & Investment opened a new position in Elevance Health (ELV) in Q2 2022: 21 shares worth $10K. The stake represents ﹤0.01% of the portfolio and ranks #217 among its holdings.

1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

Enterprise Trust & Investment held 21 shares of Elevance Health worth $10K as of Q2 2022.
Elevance Health was a new Enterprise Trust & Investment position in Q2 2022.
Elevance Health made up ﹤0.01% of Enterprise Trust & Investment's portfolio in Q2 2022, its #217 holding.
1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.